Others titles
- Current and Resolved Drug Shortages
- Current and Resolved Shortages Listed by Generic Name or Active Ingredient
Keywords
- FDA Drug Shortages
- Drug Shortages
- FDA Drug Database
- FDA Drugs
- Current Drug Shortages
FDA Drug Shortages

Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products, resource information, and relevant links.
Get The Data
- Research
Non-Commercial,
Share-Alike,
Attribution Free Forever
- Commercial
Commercial Use,
Remix & Adapt,
White Label Log in to download
Description
Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products including date first posted, updated date, therapeutic category, estimated shortage duration, resource information and relevant links.
About this Dataset
Data Info
Date Created | 2011-02 |
---|---|
Last Modified | 2022-05-09 |
Version | 2022-05-09 |
Update Frequency |
Monthly |
Temporal Coverage |
N/A |
Spatial Coverage |
United States |
Source | John Snow Labs; U.S. Food and Drug Administration (FDA); |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | FDA Drug Shortages, Drug Shortages, FDA Drug Database, FDA Drugs, Current Drug Shortages |
Other Titles | Current and Resolved Drug Shortages, Current and Resolved Shortages Listed by Generic Name or Active Ingredient |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Generic_Name_or_Active_Ingredient | Product Name | string | required : 1 |
Company_Name | Laboratory (MA Holder) | string | required : 1 |
Company_Contact_Information | Company Contact Information | string | - |
Presentation | Presentation of products including NDC | string | - |
Therapeutic_Categories | Therapeutic Categories to products | string | - |
Status | Current status of the product | string | enum : Array ( [0] => Current [1] => Resolved [2] => To Be Discontinued ) required : 1 |
Date_First_Posted | Date first posted | string | - |
Last_Update | Last status update date | date | - |
Availability_and_Estimated_Shortage_Duration | Availability and Estimated Shortage Duration | string | - |
Related_Information | Related Information about shortage | string | - |
Shortage_Reason | Shortage Reason (per Food and Drug Administration Safety and Innovation Act) | string | - |
Data Preview
Generic Name or Active Ingredient | Company Name | Company Contact Information | Presentation | Therapeutic Categories | Status | Date First Posted | Last Update | Availability and Estimated Shortage Duration | Related Information | Shortage Reason |
Abiraterone Acetate Tablets | Janssen Research and Development, LLC | 800-526-7736 | 250 mg tablets (NDC 57894-155-12) | Oncology | To Be Discontinued | 2020-06-05 | 2020-06-05 | |||
Acetazolamide Injection | Mylan Institutional, a Viatris company | 800-796-9526 | 500 mg, Lyophilisate in Single Dose Vials 1PK (NDC 67457-853-50) | Cardiovascular;Ophthalmology | Current | 2020-12-02 | 2022-05-04 | Available | Demand increase for the drug | |
Acetazolamide Injection | Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) | 800-631-2174 | 500 mg per vial (NDC 0143-9503-01) | Cardiovascular;Ophthalmology | Current | 2020-12-02 | 2022-04-08 | This presentation is temporarily on backorder. | Additional lots are scheduled for manufacturing and will be available in the May 2022 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Acetazolamide Injection | X-GEN Pharmaceuticals, Inc. | 866-390-4411 | 500mg per vial (NDC 39822-0190-1) | Cardiovascular;Ophthalmology | Current | 2020-12-02 | 2021-07-08 | Available | Check wholesaler inventory | Demand increase for the drug |
Acetazolamide Injection | Avet Pharmaceuticals, Inc. (formerly Heritage Pharma) | 855-228-9470 | 500 mg (NDC 23155-313-31) | Cardiovascular;Ophthalmology | Current | 2020-12-02 | 2022-04-12 | Available | ||
Acrivastine and Pseudoephedrine Hydrochloride Capsules | Endo Pharmaceuticals, Inc. | 800-462-3636 | Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10) | Pulmonary/Allergy | To Be Discontinued | 2020-06-02 | 2020-06-02 | Endo has made a business decision to permanently discontinue the drug product. | ||
Adalimumab (Humira) Pre-filled Syringe | Abbvie | 800-255-5162 | 10 mg/0.2 mL pre-filled syringe (NDC 0074-6347-02) | Dermatology;Gastroenterology;Ophthalmology;Rheumatology | To Be Discontinued | 2020-07-27 | 2020-07-27 | The company has discontinued manufacture of these products based on a market assessment and product demand. | ||
Adalimumab (Humira) Pre-filled Syringe | Abbvie | 800-255-5162 | 20 mg/0.4 mL pre-filled syringe (NDC 0074-9374-02) | Dermatology;Gastroenterology;Ophthalmology;Rheumatology | To Be Discontinued | 2020-07-27 | 2020-07-27 | The company has discontinued manufacture of these products based on a market assessment and product demand. | ||
Albuterol Sulfate Aerosol, Metered | Endo Pharmaceuticals, Inc. | 800-828-9393, option 5, then option 2 | 90 mcg (NDC 0254-1007-52) | Pulmonary/Allergy | To Be Discontinued | 2021-07-06 | 2021-07-06 | |||
Aliskiren and Hydrochlorothiazide Tablets | Noden Pharma | 844-399-5701 | 150 mg / 12.5 mg (NDC 70839-112-30) | Cardiovascular | To Be Discontinued | 2021-12-16 | 2021-12-16 |